About Vascular Therapies

What does Vascular Therapies do?

Vascular Therapies is a provider of biopharma solutions to improve vascular surgery outcomes in patients with kidney and vascular diseases, including Sirogen, a proprietary sirolimus formulation for local perivascular drug delivery, and ACCESS 2, a Phase 3 randomized clinical trial evaluating Sirogen’s effectiveness in improving AV fistula outcomes in elderly hemodialysis patients.

Who are Vascular Therapies's competitors?

Vascular Therapies's competitors and similar companies include Huyabio, Impulse Dynamics, Proxim Diagnostics, TriReme Medical, and Harpoon Medical.

Where is Vascular Therapies headquartered?

Vascular Therapies is headquartered in United States.

How many employees does Vascular Therapies have?

Vascular Therapies has 1,000 employees 🔒.

When was Vascular Therapies founded?

Vascular Therapies was founded in 2010 🔒.

What sector and industry vertical is Vascular Therapies in?

Vascular Therapies is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Vascular Therapies

Who are the top strategic acquirers in Vascular Therapies's sector and industry

Top strategic M&A buyers and acquirers in Vascular Therapies's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Vascular Therapies?

Top strategic M&A buyers groups and sectors for Vascular Therapies include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Vascular Therapies's sector and industry vertical

Which are the top PE firms investing in Vascular Therapies's sector and industry vertical?

Top PE firms investing in Vascular Therapies's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Vascular Therapies's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Vascular Therapies's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Vascular Therapies's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Vascular Therapies include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Vascular Therapies's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Vascular Therapies?

The key public trading comparables and valuation benchmarks for Vascular Therapies include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Vascular Therapies for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Vascular Therapies with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Vascular Therapies's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Vascular Therapies with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Vascular Therapies's' sector and industry vertical?

Access recent funding rounds and capital raises in Vascular Therapies's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.